A new sensitive UPLC-MS/MS method for the determination of cucurbitacin B in rat plasma: application to an absolute bioavailability study

Chemical profiling of Euphorbia fischeriana Steud. by UHPLC-Q/TOF-MS

(2018) Canjian Wang et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

HPLC–MS/MS analysis of mesupron and its application to a pharmacokinetic study in rats

(2018) Changmin Park et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Plasma Pharmacokinetics, Bioavailability, and Tissue Distribution of Four C-Glycosyl Flavones from Mung Bean (Vigna radiata L.) Seed Extracts in Rat by Ultrahigh-Performance Liquid Chromatography–Tandem Mass Spectrometry

(2017) Yan Bai et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Simultaneous determination of cucurbitacin B, E, I and E-glucoside in plant material and body fluids by HPLC–MS

(2017) Nicole Bajcsik et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Development and validation of a UPLC-MS/MS method for the determination of cucurbitacin B in rat plasma and application to a pharmacokinetic study

(2015) Waiou Zhao et al.   BIOMEDICAL CHROMATOGRAPHY

Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth

(2014) Yajuan Gao et al.   CANCER LETTERS

Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation

(2012) Suwit Duangmano et al.   BMC Complementary and Alternative Medicine

The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer

(2012) Ahmed Aribi et al.   INTERNATIONAL JOURNAL OF CANCER

The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug Development

(2012) Leslie Z. Benet   JOURNAL OF PHARMACEUTICAL SCIENCES

Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus

(2011) Sumana Dakeng et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration

(2010) Kin Tak Chan et al.   CANCER LETTERS

Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562

(2009) Kin Tak Chan et al.   CANCER LETTERS